ArticleFrontiers in cellular and infection microbiology2026
Automated microbial recognition from gram-stained micrographs via CNN and metadata decision support.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Accurate and timely identification of microorganisms is critical for guiding clinical decision-making, ensuring biosafety, and supporting microbiological research. Standard morphological assessments often require significant manual effort and specialized expertise, underscoring the need for automated, high-throughput diagnostic tools. This study presents an automated species-level bacterial classification pipeline that couples deep learning analysis of Gram-stained microscopy images with a clinical decision-support framework fueled by a curated microbiological metadata repository. Methods: A convolutional neural network (CNN) was trained on 2,034 brightfield microscopy images representing 33 bacterial species of clinical and industrial relevance across diverse taxa and imaging conditions. Preprocessing protocols included intensity normalization, spatial resizing, and on-the-fly data augmentation to ensure generalization. The preprocessed inputs were evaluated using a sequential CNN architecture optimized for multiscale feature extraction. The pipeline subsequently linked visual model predictions to an integrated repository containing eight laboratory-relevant metadata attributes per species, including Gram status, cellular morphology, oxygen requirement, biosafety level, and pathogenicity profiles. Results: On an independent test set, the classification model demonstrated balanced diagnostic capability, achieving an accuracy of 0.84, a weighted F1-score of 0.84, and a Matthews correlation coefficient of 0.84 across all target classes. Morphologically distinctive species, including Discussion: Coupling deep learning classification with contextual microbiological metadata yields standardized, interpretable diagnostic reports that bridge the gap between pure image recognition and actionable clinical intelligence. While morphological convergence remains a limitation for certain closely related taxa, the integration of structured metadata offers a reliable decision-support mechanism for laboratory and educational environments. This automated framework establishes a foundation for multimodal diagnostic pipelines that can incorporate biochemical assays, spectroscopic data, and expanded clinical cohorts in prospective validation studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.